Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Type 1 classical dendritic cells govern long-term cardiac allograft acceptance
Macee C. Owen, … , Daniel Kreisel, Kory J. Lavine
Macee C. Owen, … , Daniel Kreisel, Kory J. Lavine
Published July 8, 2025
Citation Information: J Clin Invest. 2025;135(18):e192811. https://doi.org/10.1172/JCI192811.
View: Text | PDF
Research Letter Cardiology Inflammation

Type 1 classical dendritic cells govern long-term cardiac allograft acceptance

  • Text
  • PDF
Abstract

Authors

Macee C. Owen, Vinay R. Penna, Hao Dun, Wenjun Li, Benjamin J. Kopecky, Kenneth M. Murphy, Daniel Kreisel, Kory J. Lavine

×

Figure 1

Type 1 classical DCs are necessary for cardiac allograft acceptance and modulate T cell phenotypes.

Options: View larger image (or click on image) Download as PowerPoint
Type 1 classical DCs are necessary for cardiac allograft acceptance and ...
(A) scRNA-Seq UMAP and (B) composition plot of mononuclear phagocytes sorted from allografts 7 days after transplantation of BALB/c hearts into CSB- (n = 3) or CSA-treated (n = 3) B6 WT mice. (C) Flow cytometry quantification of cDC1s within allografts of CSB- (n = 3) and CSA-treated (n = 3) B6 WT recipients at 7 days after transplant. (D) Immunostaining of graft-infiltrating cDCs (GFP+) and PDL1 in CSB- (n = 6) and CSA-treated (n = 5) B6 Zbtb46gfp/+ recipients of BALB/c hearts at 7 days after transplant. Scale bar: 50 μm. (E) Quantification of GFP+ and PDL1+ cells in CSB- (n = 6) and CSA-treated (n = 5) allografts at 7 days after transplant into B6 Zbtb46gfp/+ mice. (F) Kaplan-Meier survival curves of BALB/c hearts after transplantation into CSB-treated B6 WT, Δ1+2+3, and Irf8+32–/– mice (n = 10 per condition). (G) Histology (H&E, Verhoeff-Van Gieson elastin stain) of allografts from B6 WT, Δ1+2+3, and Irf8+32–/– recipients at 60 days after transplant (WT, Δ1+2+3) or time of rejection (Irf8+32–/–). Fractions in the top right corner indicate the number of samples with histology matching the representative image out of the total samples in each cohort. Scale bar: 50 μm (top); 20 μm (bottom). (H) Immunostaining of CD4+ and CD8+ T cells in allografts of B6 Irf8+32–/– (n = 3) and WT (n = 3) recipients at 14 days after transplant. Scale bar: 50 μm. (I) scRNA-Seq UMAP and (J) composition plot of subclustered T cells B6 WT (n = 3) and Irf8+32–/– (n = 3) recipients. (K) Pathway analysis of genes differentially expressed in T cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts